⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Dialogica Announces Inaugural Board of Advisors
prnewswire.com
MS
MRK
GOOG
United Airlines CEO Scott Kirby Named Executives' Club 2026 International Executive of the Year
prnewswire.com
UAL
CDW
MSFT
CRM
MRK
KO
JPM
Samsung Bioepis anuncia datos preliminares positivos de las fases 1 y 3 de SB27, un biosimilar propuesto para Keytruda (pembrolizumab)
businesswire.com
MRK
SGBX
Samsung Bioepis anuncia dados preliminares positivos das Fases 1 e 3 para o SB27, um biossimilar proposto para o Keytruda (Pembrolizumabe)
businesswire.com
MRK
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV
businesswire.com
MRK
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)
businesswire.com
MRK
Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider
globenewswire.com
TMO
BIO
MRK
Alger Russell Innovation Index Updates for Second Quarter 2026
prnewswire.com
ADBE
DOX
GNTX
KVYO
MRK
RBLX
TRMB
Z
ZS
CORT
DV
GTM
ILMN
NTAP
OKTA
P
QCOM
TDC
TWLO
ZM
In Vitro Toxicity Testing Market to Reach $28.0 Billion by 2030, Driven by Rising R&D Costs and Regulatory Push for Animal Testing Alternatives
globenewswire.com
TMO
MRK
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
businesswire.com
MRK